Skip Nav Destination
Issues
2023
ISSN 0743-6661
MORTALITY
ADVANCES IN RISK ASSESSMENT
COVID-19 PANDEMIC
HEALTH CARE INTERVENTION EFFECTIVENESS MEASUREMENT
LABORATORY TESTING
LITERATURE REVIEW
-
Cover Image
Cover Image
Get Email Alerts
Assessing the Pathophysiology, Morbidity, and Mortality of Obstructive Sleep Apnea
RC Richie, MD, DBIM, FACP, FCCP
Varicose Veins as Model for Apportionment among Risk Factors for Compensation Purposes
Marc J. Weber, MD, Physician Consultant, Mark I. Taragin, MD, MPH, Chief Medical Officer
Cancer of the Nasal Cavity, Middle Ear and Accessory Sinuses – 15 Year Comparative Survival and Mortality Analysis by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration and Topographic Primary Sites: A Systematic Review of 13,404 Cases for Diagnosis Years 2000-2017: (NCI SEER*Stat 8.3.8)
Anthony F. Milano, MD, MPH, MA, DBIM
Cancer of the Larynx–20-Year Comparative Survival and Mortality Analysis by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration and ICD-O-3 Topographic Primary Sites-Codes C32.0-9: A Systematic Review of 43,103 Cases for Diagnosis Years 1975-2017: (NCI SEER*Stat 8.3.9)
Anthony F. Milano, MD, MPH, MA, DBIM
Unlocking Hidden Risks: Harnessing Artificial Intelligence (AI) to Detect Subclinical Conditions from an Electrocardiogram (ECG)
Emoke Posan, MD, PhD, Chief Medical Officer, Life North America, PartnerRe Reinsurance, Rod Richie, MD, DBIM, FACP, FCCP